Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Post Marketing Surveillance Study of Byetta (Exenatide) Use Among Filipino Patients

Trial Profile

Post Marketing Surveillance Study of Byetta (Exenatide) Use Among Filipino Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Exenatide (Primary) ; Metformin; Sulfonylureas
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Amylin Pharmaceuticals
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Dec 2010 Planned end date changed from 1 May 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 05 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top